Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Median Effective Volume of Ropivacaine for Obturator Nerve Block in TURBT
ChiCTR2500106391Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Xi'an Medical University
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in bladder cancer, sponsored by The First Affiliated Hospital of Xi'an Medical University. Primary endpoint: Degree of adductor muscle strength reduction. Started Jul 2025; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on ChiCTR2500106391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106391.